Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
4-nitrophenyl beta-D-GlcA-(1->4)-alpha-D-GlcN-(1->4)-beta-D-GlcA
4-nitrophenyl 4-deoxy-alpha-L-threo-hex-4-enopyranosiduronic acid + beta-D-GlcA-(1->4)-alpha-D-GlcN
-
-
-
?
4-nitrophenyl beta-D-GlcA-(1->4)-alpha-D-GlcNAc-(1->4)-beta-D-GlcA
4-nitrophenyl 4-deoxy-alpha-L-threo-hex-4-enopyranosiduronic acid + beta-D-GlcA-(1->4)-alpha-D-GlcNAc
-
-
-
?
4-nitrophenyl beta-D-GlcA-(1->4)-alpha-D-GlcNAc6S-(1->4)-beta-D-GlcA
4-nitrophenyl 4-deoxy-alpha-L-threo-hex-4-enopyranosiduronic acid + beta-D-GlcA-(1->4)-alpha-D-GlcNAc6S
-
-
-
?
4-nitrophenyl beta-D-GlcA-(1->4)-alpha-D-GlcNS-(1->4)-beta-D-GlcA
4-nitrophenyl 4-deoxy-alpha-L-threo-hex-4-enopyranosiduronic acid + beta-D-GlcA-(1->4)-alpha-D-GlcNS
-
-
-
?
4-nitrophenyl beta-D-GlcA-(1->4)-alpha-D-GlcNS6S-(1->4)-beta-D-GlcA
4-nitrophenyl 4-deoxy-alpha-L-threo-hex-4-enopyranosiduronic acid + beta-D-GlcA-(1->4)-alpha-D-GlcNS6S
-
-
-
?
4-nitrophenyl beta-D-GlcA-(1->4>)-alpha-D-GlcNS-(1->4)-beta-IdoA2S-(1->4)-alpha-D-GlcNS-(1->4)-beta-D-GlcA
4-nitrophenyl 4-deoxy-alpha-L-threo-hex-4-enopyranosiduronic acid + beta-D-GlcA-(1->4>)-alpha-D-GlcNS-(1->4)-beta-IdoA2S-(1->4)-alpha-D-GlcNS
-
-
-
?
4-nitrophenyl beta-D-GlcA-(1->4)-alpha-D-GlcN-(1->4)-beta-D-GlcA
4-nitrophenyl 4-deoxy-alpha-L-threo-hex-4-enopyranosiduronic acid + beta-D-GlcA-(1->4)-alpha-D-GlcN
-
-
-
?
4-nitrophenyl beta-D-GlcA-(1->4)-alpha-D-GlcNAc-(1->4)-beta-D-GlcA
4-nitrophenyl 4-deoxy-alpha-L-threo-hex-4-enopyranosiduronic acid + beta-D-GlcA-(1->4)-alpha-D-GlcNAc
about 15fold higher catalytic efficiency than with 4-nitrophenyl beta-D-GlcA-(1->4)-alpha-D-GlcNS-(1->4)-beta-D-GlcA
-
-
?
4-nitrophenyl beta-D-GlcA-(1->4)-alpha-D-GlcNAc6S-(1->4)-beta-D-GlcA
4-nitrophenyl 4-deoxy-alpha-L-threo-hex-4-enopyranosiduronic acid + beta-D-GlcA-(1->4)-alpha-D-GlcNAc6S
-
-
-
?
4-nitrophenyl beta-D-GlcA-(1->4)-alpha-D-GlcNS-(1->4)-beta-D-GlcA
4-nitrophenyl 4-deoxy-alpha-L-threo-hex-4-enopyranosiduronic acid + beta-D-GlcA-(1->4)-alpha-D-GlcNS
-
-
-
?
4-nitrophenyl beta-D-GlcA-(1->4)-alpha-D-GlcNS6S-(1->4)-beta-D-GlcA
4-nitrophenyl 4-deoxy-alpha-L-threo-hex-4-enopyranosiduronic acid + beta-D-GlcA-(1->4)-alpha-D-GlcNS6S
-
-
-
?
beta-D-glucopyranosyluronic acid
?
-
major requirement for enzyme action is reduced sulfation, cannot cleave linkages containing unsulfated GalAP residues
-
-
?
chemically modified heparins
?
-
-
-
-
?
heparan sulfate
heparan disaccharide
-
-
-
-
?
heparan sulfate
non-sulfated di- and tetrasaccharides with terminal 4-deoxy-alpha-D-gluc-4-enuronosyl groups at their non-reducing ends + SO42-
heparan sulfate
unsaturated heparan disaccharide
-
-
-
-
?
heparin
unsaturated heparin disaccharide + ?
-
-
-
-
?
heparosan polysaccharide
heparosan oligosaccharide
-
-
-
-
?
hyaluronate
unsaturated hyaluronate disaccharide
-
no substrate of wild-type, but substrate of mutant K130C. Reaction of EC 4.2.2.1
-
-
?
IdoA2S-containing sulfated heparan hexasaccharide
?
-
-
-
?
IdoA2S-containing sulfated heparan pentasaccharide
?
-
-
-
?
N,6-sulfated glucosaminido-alpha-1,4-glucuronic acid oligosaccharide
N-sulfated glucosaminido-alpha-1,4-glucuronic acid oligosaccharide + 6-sulfated glucosaminido-alpha-1,4-glucuronic acid oligosaccharide + SO42-
-
heparitinase II
heparitinase II
?
N-acetylated heparan-sulfate
N-acetylated disaccharides
-
heparitinase I
hepartitinase I
?
N-acetylated heparan-sulfate
N-sulfated disaccharides
-
heparitinase I
hepartitinase I
?
N-sulfated heparan pentasaccharide
?
-
-
-
?
partially de-N-acetylated polysaccharide of Escherichia coli K5 strain
(DELTA4,5-unsaturated hexuronic acid)-(N-unsubstituted glucosamine)-(hexuronic acid)-(N-acetylglucosamine)
-
the polysaccharide consists of the repeating linear sequence -4GlcAbeta1-4GlcNAcalpha1-. Under controlled conditions for partial digestion, lyase III does not act at the GlcN-GlcA linkage, whereas GlcNAc-GlcA is cleaved. Under forced conditions for exhaustive digestion, the GlcN-GlcA linkage is only partially cleaved
-
-
?
partially de-N-sulfated forms of heparin
(DELTA4,5-unsaturated hexuronic acid)-(N-unsubstituted glucosamine)
-
heparinase III
-
-
?
unsulfated alpha-L-idopyranosyluronic acid
?
-
major requirement for enzyme action is reduced sulfation, cannot cleave linkages containing unsulfated GalAP residues
-
-
?
additional information
?
-
heparan sulfate
?
-
-
-
-
?
heparan sulfate
?
-
-
-
?
heparan sulfate
non-sulfated di- and tetrasaccharides with terminal 4-deoxy-alpha-D-gluc-4-enuronosyl groups at their non-reducing ends + SO42-
-
-
-
?
heparan sulfate
non-sulfated di- and tetrasaccharides with terminal 4-deoxy-alpha-D-gluc-4-enuronosyl groups at their non-reducing ends + SO42-
-
-
-
?
heparan sulfate
non-sulfated di- and tetrasaccharides with terminal 4-deoxy-alpha-D-gluc-4-enuronosyl groups at their non-reducing ends + SO42-
-
-
-
?
heparan sulfate
non-sulfated di- and tetrasaccharides with terminal 4-deoxy-alpha-D-gluc-4-enuronosyl groups at their non-reducing ends + SO42-
-
-
-
?
additional information
?
-
-
the enzyme is capable of tolerating heparin sulfate trimers containing single GlcNH2, GlcNAc6S or GlcNS6S residues, but is more than 20 times less reactive towards the secondary cleavage sites compared with the counterpart primary substrates. Hep III hydrolyzes the iduronic acid containing glyosidic linkage (GlcNS-IdoA) at similar catalytic efficiency to GlcNS-GlcA, but has a slight preference toward GlcNS-GlcA linkage over GlcNS-IdoA at the beginning of catalytic reaction
-
-
?
additional information
?
-
the enzyme is capable of tolerating heparin sulfate trimers containing single GlcNH2, GlcNAc6S or GlcNS6S residues, but is more than 20 times less reactive towards the secondary cleavage sites compared with the counterpart primary substrates. Hep III hydrolyzes the iduronic acid containing glyosidic linkage (GlcNS-IdoA) at similar catalytic efficiency to GlcNS-GlcA, but has a slight preference toward GlcNS-GlcA linkage over GlcNS-IdoA at the beginning of catalytic reaction
-
-
?
additional information
?
-
-
cleavage/degradation of heparin forming unsaturated uronic acid
-
-
?
additional information
?
-
-
the susceptibility of the oligosaccharide substrates to the enzymatic digestion is size-dependent. Hep III has a preference for cleavage of the internal glycosidic linkages over those near to nonreducing/reducing ends . Hep III hydrolyzes the IdoA-containing glyosidic linkage (GlcNS-IdoA) at similar catalytic efficiency to GlcNS-GlcA, but has a slight preference toward GlcNS-GlcA linkage over GlcNS-IdoA at the beginning of catalytic reaction. The IdoA2S residue significantly decreases the reactivity of Hep III towards its adjacent GlcNS-GlcA at reducing end of heparan sulfate oligosaccharides, but shows no obvious influence on its nearby cleavage site at the nonreducing end
-
-
?
additional information
?
-
the susceptibility of the oligosaccharide substrates to the enzymatic digestion is size-dependent. Hep III has a preference for cleavage of the internal glycosidic linkages over those near to nonreducing/reducing ends . Hep III hydrolyzes the IdoA-containing glyosidic linkage (GlcNS-IdoA) at similar catalytic efficiency to GlcNS-GlcA, but has a slight preference toward GlcNS-GlcA linkage over GlcNS-IdoA at the beginning of catalytic reaction. The IdoA2S residue significantly decreases the reactivity of Hep III towards its adjacent GlcNS-GlcA at reducing end of heparan sulfate oligosaccharides, but shows no obvious influence on its nearby cleavage site at the nonreducing end
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.009 - 0.191
heparan sulfate
0.438
hyaluronate
-
mutant K130C, pH not specified in the publication, temperature not specified in the publication
additional information
additional information
-
kinetic modeling based on inactivation data, overview
-
0.009
heparan sulfate
-
mutant H110A, pH 7.6, 35°C
0.016
heparan sulfate
-
mutant H241A, pH 7.6, 35°C
0.058
heparan sulfate
-
mutant H152A, pH 7.6, 35°C
0.059
heparan sulfate
-
mutant H424A, pH 7.6, 35°C
0.071
heparan sulfate
-
mutant H469A, pH 7.6, 35°C
0.075
heparan sulfate
-
mutant H234A, pH 7.6, 35°C
0.08
heparan sulfate
-
recombinant wild-type enzyme and mutant H225A, pH 7.6, 35°C
0.08
heparan sulfate
-
wild-type, pH not specified in the publication, temperature not specified in the publication
0.092
heparan sulfate
-
mutant H539A, pH 7.6, 35°C
0.093
heparan sulfate
-
mutant K130C, pH not specified in the publication, temperature not specified in the publication
0.098
heparan sulfate
-
mutant H36A, pH 7.6, 35°C
0.143
heparan sulfate
-
native wild-type enzyme, pH 7.6, 35°C
0.191
heparan sulfate
-
mutant H139A, pH 7.6, 35°C
0.326
heparin
-
wild-type, pH not specified in the publication, temperature not specified in the publication
0.344
heparin
-
mutant K130C, pH not specified in the publication, temperature not specified in the publication
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
1.3
hyaluronate
-
mutant K130C, pH not specified in the publication, temperature not specified in the publication
5
heparan sulfate
-
mutant H241A, pH 7.6, 35°C
22
heparan sulfate
-
mutant H225A, pH 7.6, 35°C
23
heparan sulfate
-
mutant H234A, pH 7.6, 35°C
24
heparan sulfate
-
mutant H424A, pH 7.6, 35°C
37
heparan sulfate
-
mutant H110A, pH 7.6, 35°C
56
heparan sulfate
-
mutant K130C, pH not specified in the publication, temperature not specified in the publication
68
heparan sulfate
-
mutant H139A, pH 7.6, 35°C
68
heparan sulfate
-
wild-type, pH not specified in the publication, temperature not specified in the publication
78
heparan sulfate
-
recombinant wild-type enzyme, pH 7.6, 35°C
83
heparan sulfate
-
mutant H152A, pH 7.6, 35°C
86
heparan sulfate
-
mutant H36A, pH 7.6, 35°C
94
heparan sulfate
-
native wild-type enzyme, pH 7.6, 35°C
100
heparan sulfate
-
mutant H469A, pH 7.6, 35°C
132
heparan sulfate
-
mutant H539A, pH 7.6, 35°C
1.6
heparin
-
mutant K130C, pH not specified in the publication, temperature not specified in the publication
1.9
heparin
-
wild-type, pH not specified in the publication, temperature not specified in the publication
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
C297S
-
site-directed mutagenesis, the mutant suppresses the dimerization and shows 70% reduced activity compared to the wild-type enzyme
E237A
40.8% of wild-type activitiy
F423A
42.4% of wild-type activitiy
H105A
-
PCR overlap extension site-directed mutagenesis, very low expression level, no measurement of activity possible, reduced expression level
H110A
-
PCR overlap extension site-directed mutagenesis, reduced kcat, highly reduced Km compared to both recombinant and native wild-type enzymes, reduced expression level
H139A
-
PCR overlap extension site-directed mutagenesis, reduced kcat and increased Km compared to both recombinant and native wild-type enzymes, reduced expression level
H152A
-
PCR overlap extension site-directed mutagenesis, reduced Km and a kcat value between the recombinant and the native wild-type enzyme
H225A
-
PCR overlap extension site-directed mutagenesis, Km is the same as for the recombinant wild-type, reduced kcat
H234A
-
PCR overlap extension site-directed mutagenesis, Km is similar to the recombinant wild-type, reduced kcat
H295A
-
PCR overlap extension site-directed mutagenesis, inactive mutant
H36A
-
PCR overlap extension site-directed mutagenesis, reduced Km and a kcat value between the recombinant and the native wild-type enzyme
H469A
-
PCR overlap extension site-directed mutagenesis, reduced Km and increased kcat compared to both recombinant and native wild-type enzymes
H510A
-
PCR overlap extension site-directed mutagenesis, inactive mutant
H539A
-
PCR overlap extension site-directed mutagenesis, Km between the recombinant and the native wild-type enzyme, kcat is increased compared to both wild-type enzymes
I29V/L657S
42.7% of wild-type activitiy
K130C
-
mutant is able to degrade hyaluronic acid without affecting its native activity toward heparin and heparan sulfate, due to dimerization through a disulfide bond to expand the substrate binding pocket
N240A
3.1% of wild-type activitiy
Q238A
88.5% of wild-type activitiy
W350A
27.7% of wild-type activitiy
Y294F
2.8% of wild-type activitiy
Y450F
5.6% of wild-type activitiy
Y590
7.7% of wild-type activitiy
H241A
-
PCR overlap extension site-directed mutagenesis, highly reduced kcat, highly reduced Km compared to both recombinant and native wild-type enzymes
H241A
29.7% of wild-type activitiy
H424A
-
PCR overlap extension site-directed mutagenesis, reduced Km and kcat
H424A
0.3% of wild-type activitiy
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Nader, H.B.; Dietrich, C.P.; Bounassi, V.; Colburn, P.
Heparin sequences in the heparan sulfate chains of an endothelial cell proteoglycan
Proc. Natl. Acad. Sci. USA
84
3565-3569
1987
Pedobacter heparinus
brenda
Nader H.B.; Porcionatto M.A.; Tersariol, L.S.; Pinhal, M.A.S.; Oliveira, F.W.; Moraes, C.T.; Dietrich, C.P.
Purification and substrate specificity of heparitinase I and heparitinase II from Flavobacterium heparinum. Analyses of the heparin and heparan sulfate degradation products by 13C NMR spectroscopy
J. Biol. Chem.
265
16807-16813
1990
Pedobacter heparinus
brenda
Desai, U.R.; Wang, H.W.; Linhardt, R.J.
Specificity studies on the heparin lyases from Flavobacterium heparinum
Biochemistry
32
8140-8145
1993
Pedobacter heparinus
brenda
Linhardt, R.J.; Turnbull, J.E.; Wang, H.M.; Lofanathan, D.; Gallagher, J.T.
Examination of the substrate specificity of heparin and heparan sulfate lyases
Biochemistry
29
2611-2617
1990
Pedobacter heparinus
brenda
Yamada, S.; Sakamoto, K.; Tsuda, H.; Yoshida, K.; Sugahara, K.; Khoo, K.H.; Morris, H.R.; Dell, A.
Structural studies on the tri- and tetrasaccharides isolated from porcine intestinal heparin and characterization of heparinase/heparitinases using them as substrates
Glycobiology
4
69-78
1994
Pedobacter heparinus
brenda
Suhahara, K.; Tohno-oka, R.; Yamada, S.; Khoo, K.H.; Morris, H.R.; Dell, A.
Structural studies on the oligosaccharides isolated from bovine kidney heparan sulphate and characterization of bacterial heparitinases used as substrates
Glycobiology
4
535-544
1994
Pedobacter heparinus
brenda
Brickman, M.C.; Gerhart, J.C.
Heparitinase inhibition of mesoderm induction and gastrulation in Xenopus laevis embryos
Dev. Biol.
164
484-501
1994
Pedobacter heparinus
brenda
Pojasek, K.; Shriver, Z.; Hu, Y.; Sasisekharan, R.
Histidine 295 and histidine 510 are crucial for the enzymatic degradation of heparan sulfate by heparinase III
Biochemistry
39
4012-4019
2000
Pedobacter heparinus
brenda
Chai, W.; Leteux, C.; Westling, C.; Lindahl, U.; Feizi, T.
Relative susceptibilities of the glucosamine-glucuronic acid and N-acetylglucosamine-glucuronic acid linkages to heparin lyase III
Biochemistry
43
8590-8599
2004
Pedobacter heparinus
brenda
Wei, Z.; Lyon, M.; Gallagher, J.T.
Distinct substrate specificities of bacterial heparinases against N-unsubstituted glucosamine residues in heparan sulfate
J. Biol. Chem.
280
15742-15748
2005
Pedobacter heparinus
brenda
Rops, A.L.; Jacobs, C.W.; Linssen, P.C.; Boezeman, J.B.; Lensen, J.F.; Wijnhoven, T.J.; van den Heuvel, L.P.; van Kuppevelt, T.H.; van der Vlag, J.; Berden, J.H.
Heparan sulfate on activated glomerular endothelial cells and exogenous heparinoids influence the rolling and adhesion of leucocytes
Nephrol. Dial. Transplant.
22
1070-1077
2007
Pedobacter heparinus
brenda
Babu, P.; Kuberan, B.
Fluorescent-tagged heparan sulfate precursor oligosaccharides to probe the enzymatic action of heparitinase I
Anal. Biochem.
396
124-132
2010
Pedobacter heparinus
brenda
Raman, K.; Kuberan, B.
Differential effects of heparitinase I and heparitinase III on endothelial tube formation in vitro
Biochem. Biophys. Res. Commun.
398
191-193
2010
Pedobacter heparinus
brenda
Chen, S.; Ye, F.; Chen, Y.; Chen, Y.; Zhao, H.; Yatsunami, R.; Nakamura, S.; Arisaka, F.; Xing, X.H.
Biochemical analysis and kinetic modeling of the thermal inactivation of MBP-fused heparinase I: implications for a comprehensive thermostabilization strategy
Biotechnol. Bioeng.
108
1841-1851
2011
Pedobacter heparinus
brenda
Hashimoto, W.; Maruyama, Y.; Nakamichi, Y.; Mikami, B.; Murata, K.
Crystal structure of Pedobacter heparinus heparin lyase Hep III with the active site in a deep cleft
Biochemistry
53
777-786
2014
Pedobacter heparinus (Q59289), Pedobacter heparinus, Pedobacter heparinus DSM 2366 (Q59289)
brenda
Carnachan, S.M.; Bell, T.J.; Sims, I.M.; Smith, R.A.A.; Nurcombe, V.; Cool, S.M.; Hinkley, S.F.R.
Determining the extent of heparan sulfate depolymerisation following heparin lyase treatment
Carbohydr. Polym.
152
592-597
2016
Pedobacter heparinus
brenda
Hu, G.; Shao, M.; Gao, X.; Wang, F.; Liu, C.
Probing cleavage promiscuity of heparinase III towards chemoenzymatically synthetic heparan sulfate oligosaccharides
Carbohydr. Polym.
173
276-285
2017
Pedobacter heparinus, Pedobacter heparinus (Q05819)
brenda
Gu, Y.; Lu, M.; Wang, Z.; Wu, X.; Chen, Y.
Expanding the catalytic promiscuity of heparinase III from Pedobacter heparinus
Chemistry
23
2548-2551
2017
Pedobacter heparinus
brenda
Gu, Y.; Wu, X.; Liu, H.; Pan, Q.; Chen, Y.
Photoswitchable heparinase III for enzymatic preparation of low molecular weight heparin
Org. Lett.
20
48-51
2018
Pedobacter heparinus (Q59289)
brenda